Medicinal Products

Exjade

Name Exjade
Active Substance deferasirox
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code V03AC03
Medicinal product marketed in the Croatia Da
Educational materials
for healthcare professionals
Exjade Brošura za liječnike verzija 1
Educational materials
for patients / caregivers
Exjade Brošura za bolesnike verzija 1

Note

The medicinal product has been authorised via centralised procedure in all Member States of the European Union based on the European Medicines Agency's expert opinion. Additional information on the medicinal product can be found under the following link:https://www.ema.europa.eu/en/medicines/human/EPAR/exjade

The marketing authorisation has been granted by the European Commission. All marketing authorisations of the European Commission can be found under the following link: http://ec.europa.eu/health/documents/community-register/html/index_en.htm

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o riziku od medikacijske pogreške zbog nove formulacije, novog doziranja i novog načina primjene lijeka Exjade (deferasiroks) - za liječnike 12.01.2018 Novartis Hrvatska d.o.o.
Pismo zdravstvenim radnicima o riziku od medikacijske pogreške zbog nove formulacije, novog doziranja i novog načina primjene lijeka Exjade (deferasiroks) - za ljekarnike 12.01.2018 Novartis Hrvatska d.o.o.
Back